Litcius/Paper detail

The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis

Marcelle Dina Zita, Matthew B. Phillips, Johnasha D. Stuart, Asangi R. Kumarapeli, Anthony J. Snyder, Amairani Paredes, Vijayalakshmi Sridharan, Marjan Boerma, Pranav Danthi, Karl W. Boehme

2021Journal of Virology11 citationsDOIOpen Access PDF

Abstract

Reovirus is a nonenveloped virus with a segmented double-stranded RNA genome that serves as a model for studying viral myocarditis. The mechanisms by which reovirus drives myocarditis development are not fully elucidated. We found that substituting the M2 gene from strain type 3 Dearing (T3D) into an otherwise type 1 Lang (T1L) genetic background (T1L/T3DM2) was sufficient to convert the nonlethal T1L strain into a lethal infection in neonatal C57BL/6 mice. T1L/T3DM2 disseminated more efficiently and reached higher maximum titers than T1L in all organs tested, including the heart. T1L is mildly myocarditic and induced small areas of cardiac inflammation in a subset of mice. In contrast, hearts from mice infected with T1L/T3DM2 contained extensive cardiac inflammatory infiltration and more activated caspase-3-positive cells, which is indicative of apoptosis. Together, our findings identify the reovirus M2 gene as a new determinant of reovirus-induced myocarditis.

Topics & Concepts

BiologyMolecular biologyVirologyViral gastroenteritis research and epidemiologyViral Infections and Immunology ResearchVirus-based gene therapy research
The M2 Gene Is a Determinant of Reovirus-Induced Myocarditis | Litcius